Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker Plans To Quell Japanese Pricing Cut Storm With R&D Investments

This article was originally published in The Gray Sheet

Executive Summary

Stryker will rely on developing its product pipeline in 2006 to withstand large price cuts from Japan in 2007, according to CEO Steve MacMillan

You may also be interested in...



Stryker Sales Aided By Expanding Domestic Orthopedic Implant Business

Stryker is experiencing a "resurgence" in its U.S. orthopedics division, aided by double-digit growth of reconstructive implant sales

Stryker Sales Aided By Expanding Domestic Orthopedic Implant Business

Stryker is experiencing a "resurgence" in its U.S. orthopedics division, aided by double-digit growth of reconstructive implant sales

Zimmer Anticipates Lower-Than-Expected Pricing Cuts In Japan

Zimmer predicts that upcoming Japanese pricing cuts will be less severe than expected, echoing a similar forecast by Stryker

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel